Back to search

Article

Alternative Anastrozole Target CYP4V2 Impairs Neurons in Preclinical Models of Inherited Tauopathy

2025-11-29

Abstract excerpt

Tauopathies, including Alzheimer disease, are neurodegenerative diseases characterized by the pathological aggregation of the microtubule-associated protein Tau (MAPT). This study explores the neuroprotective properties of anastrozole, a clinical Aromatase inhibitor, in both a Drosophila tauopathy model expressing human MAPT R406W and isogenic pairs of human induced pluripotent stem cell-derived cortical neurons...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ad00d99f-a600-51f6-8720-74ef42402821
DOI
10.1101/2025.11.29.689498
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Alternative Anastrozole Target CYP4V2 Impairs Neurons in Preclinical Models of Inherited TauopathyDOI 10.1101/2025.11.29.689498
Select a neighboring publication to make it the new centre.